CUSIP: 52886N117
What is CUSIP 52886N117?
CUSIP 52886N117 identifies LEXXW - Lexaria Bioscience Corp. - *W EXP 01/14/202 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 52886N117:
As of 31 Dec 2025, 2 institutional investors reported holding 23,119 shares of Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 23,119 | $97 | -$3,397 | $0.00 | 2 |
| 2025 Q3 | 85,026 | $6,802 | -$142 | $0.08 | 4 |
| 2025 Q2 | 45,446 | $4,545 | $0.10 | 2 | |
| 2025 Q1 | 45,446 | $14,989 | -$447 | $0.35 | 2 |
| 2024 Q4 | 46,530 | $39,334 | -$18,614 | $0.81 | 3 |
| 2024 Q3 | 69,516 | $63,886 | -$60,247 | $0.92 | 3 |
| 2024 Q2 | 135,473 | $109,204 | +$75,460 | $0.81 | 3 |
| 2024 Q1 | 41,850 | $62,776 | -$104,347 | $1.50 | 3 |
| 2023 Q4 | 133,842 | $123,389 | -$45,142 | $0.45 | 3 |
| 2023 Q3 | 350,928 | $133,935 | -$7,203 | $0.21 | 5 |
| 2023 Q2 | 386,700 | $125,362 | +$562 | $0.22 | 5 |
| 2023 Q1 | 384,148 | $389,197 | +$20,576 | $0.58 | 3 |
| 2022 Q4 | 351,259 | $303,113 | -$22,015 | $0.40 | 4 |
| 2022 Q3 | 532,525 | $991,000 | -$143,499 | $1.52 | 4 |
| 2022 Q2 | 591,760 | $593,000 | -$61,717 | $0.70 | 5 |
| 2022 Q1 | 680,515 | $802,000 | +$11,956 | $0.90 | 4 |
| 2021 Q4 | 666,881 | $1,204,000 | +$114,724 | $1.51 | 5 |
| 2021 Q3 | 456,921 | $1,288,000 | -$1,051,328 | $2.11 | 3 |
| 2021 Q2 | 887,101 | $2,581,000 | +$276,682 | $2.51 | 4 |
| 2021 Q1 | 776,855 | $2,111,000 | +$2,111,000 | $2.40 | 4 |